ZA200100828B - Compressed compositions comprising clarified xanthan gum. - Google Patents

Compressed compositions comprising clarified xanthan gum. Download PDF

Info

Publication number
ZA200100828B
ZA200100828B ZA200100828A ZA200100828A ZA200100828B ZA 200100828 B ZA200100828 B ZA 200100828B ZA 200100828 A ZA200100828 A ZA 200100828A ZA 200100828 A ZA200100828 A ZA 200100828A ZA 200100828 B ZA200100828 B ZA 200100828B
Authority
ZA
South Africa
Prior art keywords
xanthan gum
sustained release
ibuprofen
active ingredient
composition according
Prior art date
Application number
ZA200100828A
Other languages
English (en)
Inventor
Maureen Dixey
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of ZA200100828B publication Critical patent/ZA200100828B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA200100828A 1998-08-01 2001-01-30 Compressed compositions comprising clarified xanthan gum. ZA200100828B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9816723.2A GB9816723D0 (en) 1998-08-01 1998-08-01 Therapeutic agents

Publications (1)

Publication Number Publication Date
ZA200100828B true ZA200100828B (en) 2001-10-22

Family

ID=10836508

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200100828A ZA200100828B (en) 1998-08-01 2001-01-30 Compressed compositions comprising clarified xanthan gum.

Country Status (16)

Country Link
EP (1) EP1100471B1 (https=)
JP (1) JP2002522376A (https=)
CN (1) CN1160060C (https=)
AR (1) AR019981A1 (https=)
AT (1) ATE249815T1 (https=)
AU (1) AU744483B2 (https=)
CA (1) CA2339190C (https=)
DE (1) DE69911427T2 (https=)
DK (1) DK1100471T3 (https=)
ES (1) ES2207274T3 (https=)
GB (1) GB9816723D0 (https=)
MX (1) MXPA01000992A (https=)
NZ (1) NZ509593A (https=)
PT (1) PT1100471E (https=)
WO (1) WO2000007569A1 (https=)
ZA (1) ZA200100828B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005515966A (ja) 2001-07-06 2005-06-02 エンドー ファーマシューティカルズ, インコーポレイティド 鎮痛薬としての使用のための6−ヒドロキシ−オキシモルホンの経口投与
AU2002337686B2 (en) * 2001-09-26 2008-05-15 Penwest Pharmaceuticals Company Opioid formulations having reduced potential for abuse
CN117752805B (zh) * 2023-12-25 2024-12-24 山东聊城阿华制药股份有限公司 一种药用辅料及其制备方法
KR102881485B1 (ko) * 2024-03-22 2025-11-05 (주) 팜젠사이언스 천연첨가제에 기반한 비타민c 조성물 및 이를 포함하는 지속성 비타민c 정제

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4135979A (en) * 1976-08-24 1979-01-23 Merck & Co., Inc. Treatment of xanthan gum to improve clarity
GB8601204D0 (en) * 1986-01-18 1986-02-19 Boots Co Plc Therapeutic agents
US4915948A (en) * 1987-08-31 1990-04-10 Warner-Lambert Company Tablets having improved bioadhesion to mucous membranes
EP0399774A1 (en) * 1989-05-24 1990-11-28 Merck & Co. Inc. Composition and method for rheology controlled printing of fabric and carpet

Also Published As

Publication number Publication date
DE69911427T2 (de) 2004-07-01
JP2002522376A (ja) 2002-07-23
AU5508799A (en) 2000-02-28
AR019981A1 (es) 2002-03-27
DE69911427D1 (de) 2003-10-23
CN1160060C (zh) 2004-08-04
ES2207274T3 (es) 2004-05-16
MXPA01000992A (es) 2002-06-04
AU744483B2 (en) 2002-02-28
GB9816723D0 (en) 1998-09-30
WO2000007569A1 (en) 2000-02-17
NZ509593A (en) 2002-12-20
CA2339190C (en) 2008-11-18
PT1100471E (pt) 2003-12-31
DK1100471T3 (da) 2004-01-12
CN1354653A (zh) 2002-06-19
CA2339190A1 (en) 2000-02-17
ATE249815T1 (de) 2003-10-15
EP1100471A1 (en) 2001-05-23
EP1100471B1 (en) 2003-09-17

Similar Documents

Publication Publication Date Title
EP0234670B1 (en) Sustained-release pharmaceutical formulation containing xanthan gum
FI83037C (fi) Foerfarande foer framstaellning av en naproxen och natrium naproxentablett med styrd utloesning.
FI113336B (fi) Menetelmä tramadolisuolaa sisältävän lääkeaineen valmistamiseksi, jolla on viivästynyt vaikuttavan aineen vapautuminen
TWI330080B (en) Solid pharmaceutical compositions containing pregabalin
CN1240374C (zh) 快速崩解的甲基纤维素片剂
CN1276719A (zh) 快速崩解的甲基纤维素片剂
FR2518409A1 (fr) Preparations therapeutiques a liberation prolongee a base d'hydroxypropylmethylcellulose
JP2012514623A (ja) 1またはそれ以上のフマル酸エステルを含む医薬組成物
CN110507620B (zh) 一种复方硫酸氨基葡萄糖分散片及其制备方法
EP1906933A2 (en) Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor
JP4562797B1 (ja) 沈降炭酸カルシウムを有効成分とする口腔内崩壊錠
EP1100471B1 (en) Compressed compositions comprising clarified xanthan gum
WO2006123213A1 (en) Modified release formulations of gliclazide
EP2793853B1 (en) Pharmaceutical formulations of flurbiprofen and glucosamin
CN1172429A (zh) 使用从高等植物中可得到的粉末状水解胶体树胶的持续释放药物运送体系
JP3947244B2 (ja) 消化性潰瘍治療用製剤
US20090264495A1 (en) Oral sustained-release pharmaceutical composition of indapamide, production and use thereof
AU732785B2 (en) Process for the preparation of an oral solid dosage form containing diclofenac
JPH11246392A (ja) 経口用固形製剤
HUE029193T2 (en) Delayed release drug formulations of thiocolchicoside